Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Operating Margin (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 16 years of Operating Margin data on record, last reported at 14.62% in Q2 2025.

  • For Q2 2025, Operating Margin rose 894.0% year-over-year to 14.62%; the TTM value through May 2025 reached 13.38%, down 649.0%, while the annual FY2025 figure was 13.38%, 649.0% down from the prior year.
  • Operating Margin reached 14.62% in Q2 2025 per LFCR's latest filing, up from 25.68% in the prior quarter.
  • Across five years, Operating Margin topped out at 84.59% in Q2 2022 and bottomed at 46.89% in Q3 2024.
  • Average Operating Margin over 5 years is 3.37%, with a median of 9.15% recorded in 2021.
  • Peak YoY movement for Operating Margin: soared 6913bps in 2021, then crashed -10590bps in 2023.
  • A 5-year view of Operating Margin shows it stood at 28.58% in 2021, then crashed by -186bps to 24.48% in 2022, then skyrocketed by 80bps to 4.92% in 2023, then decreased by -22bps to 6.02% in 2024, then surged by 343bps to 14.62% in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Margin were 14.62% in Q2 2025, 25.68% in Q1 2025, and 6.02% in Q4 2024.